What We Do

HOW WE DRIVE SUCCESS

Expertise and Innovation

Unmatched Expertise: Causal inference, real-world data, and operational delivery.
Integrated Approach: An evidence framework to optimize decisions across the drug development lifecycle.

Strategic & Operational Excellence

Data-Driven Strategies: Know-how to align clinical outcomes with commercial objectives.
Operational Excellence: Ability to design large-scale real-world evidence programs with precision and efficiency.

Real World Data

Data Expertise: Continuously shaping the use of real world data in evidence generation.
Data Access: Building unique data assets.

Find Out More

SOLUTIONS

Indication Prioritization and Portfolio Strategies

Using proprietary IPPS™ framework to assess how to position the asset across the disease spectrum.

Strategic Development Plans & Market Access Strategies

Aligning drug development, market access, and regulatory strategies. Developing effective launch plans.

Advisory on Emerging
Technologies

Guidance on adopting new technologies or methodologies.

Real World Data
Advice

RWD generation planning and quality assessment for regulatory and market access purposes.

Complex RWE Design
& Execution

Design and emulation of target trials. External control arm planning, design and development.

Partnership and Collaboration
Facilitation

Establishing collaboration, including with Key Opinion Leaders to advance drug development.

REAL WORLD DATA

Clinical Insights Through
Global Real-World Data

To support regulatory decisions in rare or complex conditions, we advocate the use of clinically-rich real-world data. By tapping into these extensive datasets, our clients gain insights that drive their decisions from the inception of their products, facilitating a strategic advantage as they develop their assets.

In rare diseases, we have access to a unique data set allowing us to deliver global rare disease cohorts quickly and cost effectively.